402 related articles for article (PubMed ID: 18472256)
1. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
Xu X; Chen X; Ma P; Wang X; Jing X
Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
[TBL] [Abstract][Full Text] [Related]
2. Ultrafine medicated fibers electrospun from W/O emulsions.
Xu X; Yang L; Xu X; Wang X; Chen X; Liang Q; Zeng J; Jing X
J Control Release; 2005 Nov; 108(1):33-42. PubMed ID: 16165243
[TBL] [Abstract][Full Text] [Related]
3. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
4. A simple method to achieve high doxorubicin loading in biodegradable polymersomes.
Sanson C; Schatz C; Le Meins JF; Soum A; Thévenot J; Garanger E; Lecommandoux S
J Control Release; 2010 Nov; 147(3):428-35. PubMed ID: 20692308
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier.
Na K; Lee KH; Lee DH; Bae YH
Eur J Pharm Sci; 2006 Feb; 27(2-3):115-22. PubMed ID: 16253487
[TBL] [Abstract][Full Text] [Related]
6. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.
Zhang Y; Wu X; Han Y; Mo F; Duan Y; Li S
Int J Pharm; 2010 Feb; 386(1-2):15-22. PubMed ID: 19895878
[TBL] [Abstract][Full Text] [Related]
7. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride.
Vrignaud S; Anton N; Gayet P; Benoit JP; Saulnier P
Eur J Pharm Biopharm; 2011 Sep; 79(1):197-204. PubMed ID: 21345371
[TBL] [Abstract][Full Text] [Related]
8. Poly(L-glutamic acid)-based star-block copolymers as pH-responsive release systems.
Yan Y; Liao L; Liu D
J Control Release; 2011 Nov; 152 Suppl 1():e60-1. PubMed ID: 22195927
[No Abstract] [Full Text] [Related]
9. Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/ poly(alpha-ester) multiblock copolymer.
Kim JH; Bae YH
Eur J Pharm Sci; 2004 Nov; 23(3):245-51. PubMed ID: 15489125
[TBL] [Abstract][Full Text] [Related]
10. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
11. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
12. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
Campbell K; Craig DQ; McNally T
Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
15. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
[TBL] [Abstract][Full Text] [Related]
16. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
Park SJ; Kim SH
J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
[TBL] [Abstract][Full Text] [Related]
18. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.
Tewes F; Munnier E; Antoon B; Ngaboni Okassa L; Cohen-Jonathan S; Marchais H; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Eur J Pharm Biopharm; 2007 Jun; 66(3):488-92. PubMed ID: 17433641
[TBL] [Abstract][Full Text] [Related]
20. A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes.
Ayen WY; Kumar N
Eur J Pharm Sci; 2012 Aug; 46(5):405-14. PubMed ID: 22465658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
